Skip to main content

Table 3 Lymphedema characteristics

From: Incidence and predictors of lower extremity lymphedema after postoperative radiotherapy for prostate cancer

Lymphedema characteristics

Number of patients (14/101) (%)

Time in months from RP and LEL (median; IQR)

23.8 (9.2–36.5)

Time in months from RT and LEL (median; IQR)

4 (-0.5-17.3)

Type of LEL

Unilateral

13 (92.8)

Bilateral

1 (7.2)

Stage ISL

1

7 (50%)

2

6 (42.8)

3

1 (7.1)

Pitting

13 (12.8)

Swelling

7 (50)

Tissue thickening

2 (1.9)

Right limb Volume (ml) (median;IQR)

6 (3.9–6.5)

Left limb Volume (ml) (median;IQR)

4.9 (33.8–7.1)

Volume differences (ml) (median;IQR)

14.1 (12.3–20.5)

Active therapy (n, %)

Yes

9 (64.3%)

No

5 (35.7%)

Type of Active therapy

Bandage

4 (28.5)

Lymphatic drainage

4 (28.5)

No therapy

5 (35.7)

  1. Abbreviations: IQR: interquartile range; RP: radical prostatectomy; RT radiotherapy; ISL: International Society of Lymphology